Our Technology

Recombinant antibodies are absolutely defined by their amino acid sequence and manufactured in vitro using synthetic genes. Though recombinant antibodies are standard in the pharmaceutical industry, these antibodies have not been as widely available for research and diagnostics applications. This is starting to change, however, due to the significant benefits recombinant antibodies offer over traditional hybridoma-produced monoclonal antibodies.

Absolute Antibody was founded in 2012 with a vision to make recombinant antibodies accessible to all, and we remain the only company 100% focused on recombinant antibody technology. Follow the links below to learn more about recombinant antibodies and the recombinant antibody solutions we offer to customers worldwide.